Invasive Fungal Infections clinical trials at UC Davis
1 research study open to eligible people
Showing trials for
Evaluate F901318 Treatment of Invasive Fungal Infections in Patients Lacking Treatment Options
open to eligible people ages 16 years and up
A study to evaluate F901318 (study drug) for the treatment of invasive fungal infections in patients lacking suitable alternative treatment options.
Sacramento, California and other locations
Our lead scientists for Invasive Fungal Infections research studies include George R. Thompson, III.
Last updated: